← FDA Drug Approvals (Drugs@FDA)

TADALAFIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHANDONG · Approved 2024-03-04

Drug application

FDA Application #

ANDA216279

Application type

Abbreviated New Drug Application (Generic)

Brand name

TADALAFIL

Generic name

Tadalafil

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SHANDONG

First approval

2024-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown